Investor directory

Novo Holdings

Novo Holdings, established in 1999, is a Danish asset management firm based in Copenhagen. It serves as the investment arm of the Novo Nordisk Foundation, managing its assets and wealth. The company's primary focus is the life science sector, with a diversified portfolio comprising equities, bonds, real estate, infrastructure, and private investments. Novo Holdings maintains a significant influence on Novo Nordisk A/S and Novozymes A/S, ensuring these companies align with the Novo Group's visions and values. It also invests in early and growth-stage life science companies through its venture capital arm, Novo Ventures, which targets investments ranging from USD 5 million to USD 30 million.
http://www.novoholdings.dk
https://takcharkh.com
https://crunchbase.com/organization/novo-a-s
https://linkedin.com/company/novo-a-s
https://pitchbook.com/profiles/investor/11259-55
https://signal.nfx.com/firms/novo-ventures
https://twitter.com/novoholdings
https://www.capitaliq.com/CIQDotNet/company.aspx?companyId=980152

Sibel Arnes

Associate

Nis Bjørnholt Bak

Principal

Scott Beardsley

Managing Partner

Raymond Camahort

Principal at Novo Ventures

Lily Chang

Vice President, Growth Investments

Kartik Dharmadhikari

Partner, Bioindustrial Investments

Thomas Dyrberg

Partner

Morten Graugaard Døssing

Investment Director

Aleks Engel

Partner, Novo Holdings (Novo Seeds) and Director, REPAIR Impact Fund

Anna Fan

Senior Partner, Life Sciences Operating Committee, Venture Investments, Venture Investments (US) Inc

Thomas Grotkjær

Investor and Principal

Kenneth Harrison Ph.D

Senior Partner

Kuang He Ph.D

Vice President, Seed Investments

Stephen van Helden

Principal, Bioindustrial Investments, Growth Investments

Deepa Hingorani

Partner, Planetary Health Investments

Johan Hueffer

Senior Partner, Principal Investments

Amit Kakar

Managing Partner and Head of Novo Holdings Asia

Navjeewan Khosla

Partner, Novo Holdings Equity Asia

Max Klement

Principal, Venture Investments

Nilesh Kumar

Senior Principal

Kasim Kutay

CEO

Abhijeet Lele

Senior Partner and Head of US Principal Investments

Jeffrey Low, MD

Principal

Heather Ludvigsen

Senior Manager, Venture Investments

Nanna Lüneborg

Principal

Joseph Markson Ph.D

Principal, Venture Investments

Peter Moldt

Partner

Daniel O'Connell

Partner, Venture Investments

Daniel Rasmussen

Principal, Seed Investments

Naveed Siddiqi

Senior Partner, Venture Investments

Eric Snyder

Partner, Venture Investments

Jim Trenkle

Partner, Venture Investments

Past deals in Africa

Sylvan

Private Equity Round in 2025
Sylvan Inc. is a biotechnology company that specializes in the production and distribution of mushroom spawns, including agaricus, pleurotus, shiitake, and casing inoculum. Established in 1946 and based in Kittanning, Pennsylvania, Sylvan operates production and sales facilities across multiple countries, including the Netherlands, France, Hungary, Ireland, South Africa, Australia, and various locations in the United States. The company also provides disease control products for mushrooms, nutritional supplements, and nicolon nets. In addition to its production capabilities, Sylvan supports the food, health, agriculture, and materials industries through solid-state fermentation technology. The company emphasizes a collaborative approach to innovation and value creation in fungal biotechnology. As of 2019, Sylvan operates as a subsidiary of Jiangsu Yuguan Modern Agricultural S&T Co., Ltd.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.